677 Inhibition of p38 MAP kinase improves endothelial dysfunction in chronic heart failure: role of vascular superoxide anion production

MLA

Widder, J., et al. “677 Inhibition of P38 MAP Kinase Improves Endothelial Dysfunction in Chronic Heart Failure: Role of Vascular Superoxide Anion Production.” European Journal of Heart Failure. Supplements, vol. 2, no. 1, June 2004, p. 139. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=13022589&authtype=sso&custid=ns315887.

APA

Widder, J., Behr, T. M., Hu, K., Berova, M., Angermann, C. E., Ertl, G., & Bauersachs, J. (2004). 677 Inhibition of p38 MAP kinase improves endothelial dysfunction in chronic heart failure: role of vascular superoxide anion production. European Journal of Heart Failure. Supplements, 2(1), 139.

Chicago

Widder, J., T.M. Behr, K. Hu, M. Berova, C.E. Angermann, G. Ertl, and J. Bauersachs. 2004. “677 Inhibition of P38 MAP Kinase Improves Endothelial Dysfunction in Chronic Heart Failure: Role of Vascular Superoxide Anion Production.” European Journal of Heart Failure. Supplements 2 (1): 139. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=13022589&authtype=sso&custid=ns315887.